Blue Horseshoe Stocks: TBIO Recap & More

Transgenomic, Inc. TBIO

After noticing the stock’s significant premarket bullishness, we placed TBIO in yesterday morning’s report, and it’s a good thing that we did. It responded with a meteoric rise on the day en route to a very strong close.

TBIO traded in a daily range from a low of .67 up as high as 1.27, making intraday gains of up 90% possible, and the activity came on a torrent of volume, in the neighborhood of more than 37X the 3-month average volume.

TBIO continued to plow upward in post-market trading, and this morning has changed hands for as much as 1.64 a share in the premarket. Given the present circumstances, we wouldn’t be at all surprised to see the stock attain new highs once again today.

Puration, Inc. PURA

We were also keeping an eye on PURA, listing it in yesterday’s watchlist, and the stock recorded a modest yet solid session. On roughly eight times the monthly average, it traded up from a low of  .037 to .0482, a 30% increase.

PURA has been on a fairly steady upswing for most of this month so far, yesterday’s activity just being an extension of that pattern, so we’ll be on the lookout for a continuation of that current trend.

Ampliphi Biosciences Corp. APHB

We want to signal APHB as a possible bottom-bounce play this morning. Between it just showing a flicker of life off of recent relative lows, and the fact that it was trading at triple its current value just three months ago, we definitely want to keep this one on watch.

We’ve included a snap of the current chart, which illustrates what we’re talking about. This has the potential to become a solid recovery play in the days and/or weeks ahead.

Extended Watchlist:

Blue Horseshoe Stocks: 3 Stocks Hitting All-Time Highs

Uranium Resources, Inc. URRE

First thing this morning, we want to highlight the recent performance of URRE, which we slated for tracking in last Friday’s report. It has since made an appreciable move to the upside that is worthy of note.

We saw shares changing hands for as little as 1.62 before yesterday’s session carried the stock to a new high of 3.94, demonstrating a rise of 143% in just a few days’ time. Yesterday’s big push also came on record volume, to the tune of more than 25M shares traded.

It puts the stock in unprecedented territory in terms of momentum, so we’ll be very interested to watch the activity unfold from this point forward. We would have to surmise that a signifcant dip-and-rip could very likely take place at some point in the near future, so we’ll be looking to time that to our advantage.

OWC Pharmaceutical Research Corp. OWCP

Continuing along with our coverage of OWCP’s stellar performance this week, we have yet another new high to report this morning. We mentioned yesterday that the stock was trading at its highest prices since 2014, a fact which firmly designates OWCP as a Blue Sky Breakout play, and lo and behold, the breakout was destined to continue for yet another session.

The stock traded in a range from .26 to .41, an intraday pop of 58% which occurred on the highest volume in more than two months. The new high achieved pushed our already mind-melting observed range on the stock since our alert on September 29th, to an incredible 9011% in less than ten weeks!

Like the above-mentioned play, OWCP is now in uncharted waters, trading at its highest PPS levels of all time, and thus must be characterized as a Blue Sky Breakout, and treated as such.


Also coming out of yesterday’s premarket report to make quite a respectable intraday move was PMEA. This subpenny play traded in a range from .0008 to .0015 for a solid 87% move on the day.

Incidentally, it represented the third mention of the morning yesterday that would go on to set a new all-time high!

Galectin Therapeutics, Inc. GALT

Lastly, we want to radar an unfamiliar stock in GALT this morning after noticing a ripening chart setup. We have included a snapshot below pointing out the various aspects that we find attractive.

We’re going to place GALT on watch in the days and weeks ahead. A filling of the highlighted gap on the chart and return to September pricing, from current levels, would be a move of more than 100%

Extended Watchlist:

Blue Horseshoe Stocks: TBIO Review & More

Transgenomic, Inc. TBIO

TBIO was included in yesterday’s morning report, and the stock recorded a notable session with the help of a favorable press release. The stock started out from an early low of 1.58, and ran 29% to 2.04, dipped back to 1.77 before going on to hit its high of day at 2.11, an added 19% swing. Volume was immense, to the tune of more than nine times the 3-month average.

The news release from yesterday was pertaining to the company’s claim that they’ve developed the most comprehensive test to date for the diagnosis of Leukodystrophy, a disorder that has been notoriously difficult to diagnose; in many cases taking years. >>VIEW PR

There are a number of attractive features of the TBIO chart even after the considerable run it has enjoyed over the past few days- The strengthening RSI just broke the 50-line, and the MACD is gearing up for a bullish cross.

We’ll look for TBIO to continue registering higher lows, preferably above the 50DMA of 1.76, and for it to test resistance in the channel between yesterday’s high of 2.11 and the 200DMA of 2.15. TBIO certainly has a history of making breakout-type moves; twice this year the stock has traded for more than 3.50.

New Options Ideas

We’ve identified a couple of fresh options ideas to pass along to our readers this morning. For each of the following movers, we’ll be on the lookout for the occurrence of a dip-and-rip scenario Both stocks are gapping up here in the premarket.

FitBit, Inc. FIT

For FIT, we are going to monitor Weekly Calls (Friday Expiration) in the $45.50-48 range. We want to pay close attention to them the next couple of sessions as FIT has been establishing higher highs and higher lows on the chart. We’re watching for a dip from profit-taking, and subsequent rebound. If and when that happens, we should see some nice action in the range we highlighted.

Netflix, Inc. NFLX

As for NFLX, which has brought us serious options trading success in the past, we’re going to look for chances in Weekly Calls priced from $100-105. The stock just underwent a forward split, and there is some precedent for price increases following such an event (e.g. AAPL).

Extended Watchlist:

Blue Horseshoe Stocks: CLTX Recap & More

Celsus Therapeutics Plc. CLTX

The big winner from yesterday’s report turned out to be CLTX. We tagged the stock after catching it on a routine news scan; the company announced an all-stock exchange agreement with Volution Immuno Pharmaceuticals in which CLTX will absorb the company as a wholly-owned subsidiary, and form a new company aimed at developing treatments for a range of rare and orphan autoimmune and inflammatory diseases >> READ PR

Back in February, a bleak annual report led CLTX to fall off of a cliff, tumbling from the $6+ range down to roughly a dollar. Over the next several months, the stock continued to trend downward, culminating in a 52-week low of .40 at the end of May. Since that time, it received a little boost, rising to the .60-range.

That’s where we came upon it yesterday, and it was fortunate that we began paying attention when we did. After dipping to a daily low of .5012, the stock ran into the close, reaching a high of .68; a solid 36% intraday move. The late boost of momentum is carrying over into the premarket today, with CLTX hitting an early high of .99. From our observed low yesterday, that’s a 98% swing.

We’ll look for it to continue to build its base with higher lows, and to potentially crack through resistance into dollar-territory.

Callaway Golf Co. ELY

ELY is contributing to the newsreel this morning, announcing the signing of a highly talented young golfer. Upon taking notice of this, we’ve also seen that ELY has been building a heck of a chart setup over the past few sessions.

The stock has registered higher lows for each of the last four consecutive trading sessions, and is exhibiting a great deal of promise with regard to a number of bullish signals on the chart that we’ve pointed out on the snapshot below. Between that, and it being the peak of golf season, we’ll be paying close attention to ELY.

CARLSBAD, Calif., July 14, 2015 /PRNewswire/ – Today Callaway Golf officially announced that it has reached a Staff Pro agreement with former college golf phenom, Julien Brun. A native of Anitbes, France, Brun turns pro after an unbelievable career at Texas Christian University (TCU), where he was a 3-time First Team All-American and a 3-time Academic All-American.>> FULL PR

EnteroMedics, Inc.  ETRM

Speaking of ripening charts, we’ve got to tag ETRM this morning as a bottom-play that could be in line for a serious rebound. One look at the chart is all it takes to see what we mean.

We’ve got an egregiously oversold RSI, and the stock has fallen to new 52-week lows in the past couple of sessions.  There are also a couple of gaps to fill from 44-.50 and from .83-.96 on a possible retrace, so we’ll be monitoring this play which we feel has breakout potential based on these factors.

Extended Watchlist:

Blue Horseshoe Stocks: Options Update & Much More

Amedica Corp. AMDA

After providing us with the chance for intraweek gains of 61% last week, as we were mentioning in yesterday’s morning report, AMDA turned in another healthy performance for the day.

From a morning low of .58, the stock pressed to a new high of .70; a 21% intraday move, and this morning the stock is gapping up once again. As of this morning’s premarket high, the total range we’ve now observed in AMDA in just a week’s time stands at 102% from last Tuesday’s low of .3851.

Yesterday’s solid showing also marked the fifth consecutive trading day that AMDA managed to register higher lows and higher highs. We’ll continue to track its activity as the week progresses. A dip-and-rip off of this morning’s new high is a distinct possibility.

Under Armour, Inc. UA – Options Update

UA was a point of focus for us on Friday morning, at which time we submitted a medium-term options idea for the stock, namely the 07/31 $84 Calls. We wanted to provide an update on the subsequent performance of those contracts, which managed a notable increase between Friday and yesterday.

From a low of 2.76, the July $84′s have traded as high as 3.53 thus far. That hashes out to total possible gains of 28% over just a couple of trading sessions. With plenty of time left until expiration, we’ll be sure to keep a slot reserved for those contracts from this point forward.

TapImmune, Inc. TPIV

We’ve been tracking TPIV for nearly two weeks now. We tagged it for the first time on June 10th, and we slipped a reminder into Friday’s report as well.

We certainly hope those alerts caught someone’s attention, because TPIV has certainly caught ours; yesterday’s high of 1.23 represented a 28% jump from the low following Friday’s alert (.962) and an overall increase of 71% from the low following our initial alert (.72).

Sipp Industries, Inc. SIPC

SIPC is catching our attention this morning after announcing the addition of “Hemp co-packing, storage, distribution, and private label solutions to product offering.” in an early PR. It caused us to take notice of the chart, which is currently boasting an attractive setup with regard to its potential as a bottom-play. We’re going to keep a close eye on SIPC as we head into mid-week.

Extended Watchlist: